🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Patients with Unruptured IntraCranial ANeurysms: Evaluation of the Benefits of Allied Health FollOw-uP in a RandomizEd Controlled Trial

RecruitingNAAges 18 Years - anyAllNantes University Hospital
NCT06708078 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The CANHOPE study falls within the scope of research on patients' experiences and the improvement of their management through interventions meeting their needs. The study protocol assesses a support program for patients with untreated intracranial aneurysms (ICAs), for whom several sources of data converge in describing inadequacies in patients' care pathway and a deleterious impact on their health. The initial questioning is based on the practice of caregivers, who are witnesses of patients' feelings during ICA follow-up and are sometimes unable to support them due to a lack of knowledge about the impact of the disease and an organization that does not provide any space dedicated to their support. The study topic described below explains the medical context of ICA, and the data available in the literature on the impact of this condition on patients' lives. These data are complemented

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient with newly diagnosed (\<9 months) untreated Intracranial Aneurysm * Patient with untreated Intracranial Aneurysm monitored by imaging * Patient over 18 * Patient agreeing to participate in the study and having signed the consent form Exclusion Criteria: * Patient with a history of ruptured Intracranial Aneurysm * Patient under guardianship or curatorship * Patient diagnosed with a syndrome known to cause Intracranial Aneurysm : * Marfan syndrome * AOS (Aneurysm Osteoarthritis Syndrome) with SMAD 3 mutations * Type II and IV Elhers Danlos syndrome * Autosomal dominant polycystic fibrosis * Moya-Moya syndrome * Patient with: * Dissecting or fusiform Intracranial Aneurysm * Intracranial Aneurysm associated with an arteriovenous malformation * Blister-like Intracranial Aneurysm * Mycotic Intracranial Aneurysm
💊

What it tests

  • Follow-up according to the Canhope allied health support program
📍

Where

1 site
CHU Nantes
Nantes, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy